Molecular non-infectious disease diagnostics, POC diabetes and histology will contribute the most growth to the U.S. IVD market.
ARLINGTON, Va. (PRWEB)
November 15, 2022
Abbott is the #1 vendor in the United States in vitro diagnostics (IVD) market, according to United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, a recent report from medical market researcher Kalorama Information. Roche is second and Danaher (which includes Radiometer, Beckman Coulter and Cepheid) was third.
These leading companies compete in a $54 billion market, according to the report, the 4th edition of Kalorama’s dedicated analysis of the United States market. Kalorama publishes reports on the in vitro diagnostics markets and has been for over two decades.
The U.S. IVD market is highly developed and, in some segments, dominated by a handful of leading market players. In addition to molecular non-infectious disease diagnostics (+9.7%), POC diabetes (+5.9%) and histology (+4.3%) are expected to contribute the most growth to the U.S. IVD market.
Future U.S. IVD market growth will be a product of several factors including demographic aging; diminishing year-over-year gains on patient volumes and healthcare utilization; modest economic growth and stability in the U.S. market; and the introduction of new diagnostic technologies, particularly in the treatment of cancer and critical infections.
More information and specific market share percentages can be found in Kalorama Information’s report, In Vitro Diagnostic (IVD) Tests, 4th Edition, for sale at: https://kaloramainformation.com/product/united-states-market-for-in-vitro-diagnostic-ivd-tests-2022/
About Kalorama Information:
Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.
Share article on social media or email: